LAUSR

Women are underrepresented in medicine across numerous specialties, both as authors of scholarly work and in positions of leadership. 1 Growing interest in sex and gender representation in medicine has led to deeper scrutiny of these disparities, demonstrating the near-universality of the dearth of women in these roles and the lack of change in recent years. This inequity extends to clinical trial leadership, which is concerning, as clinical trials play a critical role in generating high-quality evidence to guide clinical practice. The benefits of increasing diversity in clinical trial leadership extend broadly to professionals and patients. 2 Perhaps most importantly, multiple investigations have demonstrated that clinical trials with women lead authors enroll greater proportions of women participants. 2-4 Thus, achieving commensurate representation of women in clinical trial leadership is a goal with both ideological and practical underpinnings: we seek to achieve equity in medicine on its own merits, as well as for its potential to propagate further benefits throughout society. Elsewhere in JAMA Network Open